PCSK9 inhibition with evolocumab (AMG 145) in heterozygous...

The Lancet 2015 / 01 Vol. 385; Iss. 9965

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Raal, Frederick J, Stein, Evan A, Dufour, Robert, Turner, Traci, Civeira, Fernando, Burgess, Lesley, Langslet, Gisle, Scott, Russell, Olsson, Anders G, Sullivan, David, Hovingh, G Kees, Cariou, Bertra
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
385
Language:
english
Journal:
The Lancet
DOI:
10.1016/s0140-6736(14)61399-4
Date:
January, 2015
File:
PDF, 361 KB
english, 2015
Conversion to is in progress
Conversion to is failed